期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

磁共振在肝纤维化诊断中的应用价值

暂未订购
导出
摘要 长期以来，肝纤维化的诊断以穿刺活检病理作为金标准，但其缺陷是其为有创伤性检查，且存在一定并发症，患者不易接受，同时肝纤维化的分布不均匀。易出现假阴性结果。血清学指标的检测中，单个指标的诊断价值有限，故多采用血清学指标联合测定的方法来进行诊断和定期随访^[1]。但由于肝脏的代偿功能较强，因而对肝纤维化的早期诊断价值有限．且血清学指标的测定也不能用于分级。
作者 严福华 周梅玲
机构地区 复旦大学附属中山医院放射科
出处 《诊断学理论与实践》 2009年第2期137-140,共4页 Journal of Diagnostics Concepts & Practice
关键词 磁共振成像 对比剂 弥散 灌注 频谱 肝脏 纤维化
分类号 R575 [医药卫生—消化系统] R445.2 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献21

  • 1陈煜,王宝恩,贾继东,钱林学,王泰龄,陈敏华,陈光勇,贺文,丁惠国,尹珊珊,张岩,董忠.慢性乙型肝炎肝纤维化程度的无创性评估[J].中华肝脏病杂志,2003,11(6):354-357. 被引量：69
  • 2Semelka RC,Chung JJ,Hussain SM,et al.Chronic hepatitis:correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience[J].J Magn Reson Imaging,2001,13(3):385-391.
  • 3范明霞,周康荣,沈继章,陈财忠.大鼠CCl_4诱发的肝纤维化模型Mn-DPDP MR研究[J].临床放射学杂志,2004,23(8):722-726. 被引量：3
  • 4Kato N,Ihara S,Tsujimoto T,et al.Effect of resovist on rats with different severities of liver cirrhosis[J].Invest Radiol,2002,37(5):292-298.
  • 5Aguirre DA,Behling CA,Alpert E,et al.Liver fibrosis:noninvasive diagnosis with double contrast material-enhanced MR imaging[J].Radiology,2006,239(2):425-437.
  • 6Muller MF,Prasad P,Siewert B,et al.Abdominal diffusion mapping with use of a whole-body echo-planar system[J].Radiology,1994,190(2):475-478.
  • 7Kim T,Murakami T,Takahashi S,et al.Diffusion-weighted single-shot echoplanar MR imaging for liver disease[J].AiR Am J Roentgenol,1999,173(2):393-398.
  • 8Ichikawa T,Haradome H,Hachiya J,et al.Diffusionweighted MR imaging with a single-shot echoplanar sequence:detection and characterization of focal hepatic lesions[J].AJR Am J Roentgenol,1998,170(2):397-402.
  • 9Aube C,Racineux PX,Lebigot J,et al.Diagnosis and quantifcation of hepatic fibrosis with diffusion weighted MR imaging:preliminary results[J].J Radiol,2004,85(3):301-306.
  • 10Lewin M,Poujol-Robert A,Boelle PY,et al.Diffusionweighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C[J].Hepatology,2007,46(3):658-665.

二级参考文献18

  • 1韩德五 马学惠 等.肝硬化动物模型的研究[J].山西医药杂志,1979,(1):1-1.
  • 2Bernardino ME, Young SW, Lee JKT, et al. Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease. Invest Radiol, 1991, 26:148
  • 3Ni Y, Marchal G. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents:an overview of preclinical animal experiments. Top Magn Reson Imaging, 1998, 9:183
  • 4Sidhu MK, Muller HH, Aggeler J,et al. Manganese dipyridoxal dippyridoxal diphosphate-enhanced magnetic resonance imaging in the evaluation of hepatocyte function. Invest Radiology, 1993, 28:903
  • 5Coley BD, Mattrey RF, Baker KG, et al. MR imaging assessment of experimental hepatic dysfunction with Mn-DPDP. JMRI, 1995, 5:11
  • 6郭慕依,叶诸榕,主编.病理学.上海:上海医科大学出版社,1994,123
  • 7Kato N, Takahashi M, Ihara S, et al. Efficacy and safety of liverspecific MRI contrast agents in rats with hepatitis and cirrhosis. Acad Radiol, 1998, 1:83
  • 8Murakami T, Baron RL, Federle MP,et al. Cirrhosis of the liver: MR imaging with Mangafodipir Trisodium (Mn-DPDP). Radiology, 1996,198: 567
  • 9Marti-Bonmati L, Lonjedo E, Poyatos C, et al. MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers. Invest Radiol, 1998, 33:712
  • 10Nelson RC, Chezmar JL, Newyle LB, et al. Manganese dipyridoxal diphoshate. Effect of dose, time and pulse sequence on hepatic enhancement in rats. Invest Radiol, 1991, 26:569

共引文献70

诊断学理论与实践
2009年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部